Jade Biosciences, Inc. business relationships
Companies named in Jade Biosciences, Inc.’s 10-K filed 2026-03-06, and public companies whose annual reports name Jade Biosciences, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.2 / 10
- AI naming
- <1 / 100 Top 23% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Jade Biosciences, Inc.’s annual report 1
“On February 3, 2025, we entered into an amended and restated cell line license agreement (the "Cell Line License Agreement") with WuXi Biologics Ireland Limited ("WuXi Biologics Ireland").” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.